Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 26;10(3):175.
doi: 10.3390/biology10030175.

On Urinary Bladder Cancer Diagnosis: Utilization of Deep Convolutional Generative Adversarial Networks for Data Augmentation

Affiliations

On Urinary Bladder Cancer Diagnosis: Utilization of Deep Convolutional Generative Adversarial Networks for Data Augmentation

Ivan Lorencin et al. Biology (Basel). .

Abstract

Urinary bladder cancer is one of the most common urinary tract cancers. Standard diagnosis procedure can be invasive and time-consuming. For these reasons, procedure called optical biopsy is introduced. This procedure allows in-vivo evaluation of bladder mucosa without the need for biopsy. Although less invasive and faster, accuracy is often lower. For this reason, machine learning (ML) algorithms are used to increase its accuracy. The issue with ML algorithms is their sensitivity to the amount of input data. In medicine, collection can be time-consuming due to a potentially low number of patients. For these reasons, data augmentation is performed, usually through a series of geometric variations of original images. While such images improve classification performance, the number of new data points and the insight they provide is limited. These issues are a motivation for the application of novel augmentation methods. Authors demonstrate the use of Deep Convolutional Generative Adversarial Networks (DCGAN) for the generation of images. Augmented datasets used for training of commonly used Convolutional Neural Network-based (CNN) architectures (AlexNet and VGG-16) show a significcan performance increase for AlexNet, where AUCmicro reaches values up to 0.99. Average and median results of networks used in grid-search increases. These results point towards the conclusion that GAN-based augmentation has decreased the networks sensitivity to hyperparemeter change.

Keywords: AlexNet; VGG16; data augmentation; deep convolutional generative adversarial networks; urinary bladder cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Dataflow diagram of Convolutional Neural Network-based (CNN) utilization in urinary bladder cancer diagnosis.
Figure 2
Figure 2
Representation of all four cystoscopy dataset classes.
Figure 3
Figure 3
The process of Generative Adversarial Networks (GAN) use for a single image type is shown. Data is split into training and testing sets, and training set is used to generate additional images. Generated images are mixed with existing dataset and used for training, generating models which are finally evaluated on the testing set.
Figure 4
Figure 4
Illustration of generation process of generation and discrimination of images.
Figure 5
Figure 5
Comparison of images representing healthy mucosa generated by GAN executed for: 100 (a), 250 (b) 500 (c) and 1000 (d) epochs respectively.
Figure 6
Figure 6
Illustration of a cross-validation procedure adapted for GAN-based augmentation.
Figure 7
Figure 7
Median, average AUCmicro¯ and standard deviation of AUCmicro¯ and σ(AUCmicro) for the case of AlexNet trained with images generated by GAN in 100 epochs.
Figure 8
Figure 8
Median, average AUCmicro¯ and standard deviation of AUCmicro¯ and σ(AUCmicro) for the case of AlexNet trained with images generated by GAN in 250 epochs.
Figure 9
Figure 9
Median, average AUCmicro¯ and standard deviation of AUCmicro¯ and σ(AUCmicro) for the case of AlexNet trained with images generated by GAN in 500 epochs.
Figure 10
Figure 10
Median, average AUCmicro¯ and standard deviation of AUCmicro¯ and σ(AUCmicro) for the case of AlexNet trained with images generated by GAN in 1000 epochs.
Figure 11
Figure 11
Median, average AUCmicro¯ and standard deviation of AUCmicro¯ and σ(AUCmicro) for the case of VGG-16 trained with images generated by GAN in 100 epochs.
Figure 12
Figure 12
Median, average AUCmicro¯ and standard deviation of AUCmicro¯ and σ(AUCmicro) for the case of VGG-16 trained with images generated by GAN in 250 epochs.
Figure 13
Figure 13
Median, average AUCmicro¯ and standard deviation of AUCmicro¯ and σ(AUCmicro) for the case of VGG-16 trained with images generated by GAN in 500 epochs.
Figure 14
Figure 14
Median, average AUCmicro¯ and standard deviation of AUCmicro¯ and σ(AUCmicro) for the case of VGG-16 trained with images generated by GAN in 1000 epochs.
Figure 15
Figure 15
Comparison of achieved results.

References

    1. Zlatev D.V., Altobelli E., Liao J.C. Advances in imaging technologies in the evaluation of high-grade bladder cancer. Urol. Clin. 2015;42:147–157. doi: 10.1016/j.ucl.2015.01.001. - DOI - PMC - PubMed
    1. Cancer Genome Atlas Research Network Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507:315–322. doi: 10.1038/nature12965. - DOI - PMC - PubMed
    1. Takahashi K., Kimura G., Endo Y., Akatsuka J., Hayashi T., Toyama Y., Hamasaki T., Kondo Y. Urothelial carcinoma of the bladder, lipid cell variant: A case report and literature review. J. Nippon. Med Sch. 2019 doi: 10.1272/jnms.JNMS.2019_86-602. - DOI - PubMed
    1. Dotson A., May A., Davaro F., Raza S.J., Siddiqui S., Hamilton Z. Squamous cell carcinoma of the bladder: Poor response to neoadjuvant chemotherapy. Int. J. Clin. Oncol. 2019;24:706–711. doi: 10.1007/s10147-019-01409-x. - DOI - PubMed
    1. Celis J.E., Wolf H., Østergaard M. Bladder squamous cell carcinoma biomarkers derived from proteomics. Electrophor. Int. J. 2000;21:2115–2121. doi: 10.1002/1522-2683(20000601)21:11<2115::AID-ELPS2115>3.0.CO;2-K. - DOI - PubMed

LinkOut - more resources